Publications

• Safety and efficacy of repeat ivermectin mass drug administrations for malaria control (RIMDAMAL II): a phase 3, double-blind, placebo-controlled, cluster-randomised, parallel-group trial.Somé AF, Somé A, Sougué E, Ouédraogo COW, Da O, Dah SR, Nikièma F, Magalhaes T, Gray LI, Finical W, Pugh G, Lado P, Randall JC, Burton TA, Ring ME, Leon AS, Colt M, Li F, Wang K, Wade M, Lier AJ, Richards K, Sproch H, Zhang E, Ellman J, Achebe I, Jackson CL, Xiao M, Wu EJ, Bousema T, Slater HC, Foy BD, Parikh S, Dabiré RK. Lancet Infect Dis. 2025 Feb 4; 2025 Feb 4. PMID: 39919778.
• Extended Treatment Duration of Artemether-Lumefantrine in Ugandan Children with HIV on Efavirenz-Based Antiretroviral Therapy: A Randomized Controlled Pharmacokinetic and Pharmacodynamic Trial.Whalen ME, Kajubi R, Goodwin J, Orukan F, Colt M, Huang L, Richards K, Hoffmann TJ, Aweeka FT, Parikh S, Mwebaza N. J Clin Pharmacol. 2025 Jan 24; 2025 Jan 24. PMID: 39853752.
• Two mosquito salivary antigens demonstrate promise as biomarkers of recent exposure to P. falciparum infected mosquito bites.Lapidus S, Goheen MM, Sy M, Deme AB, Ndiaye IM, Diedhiou Y, Mbaye AM, Hagadorn KA, Sene SD, Pouye MN, Thiam LG, Ba A, Guerra N, Mbengue A, Raduwan H, Gagnon J, Vigan-Womas I, Parikh S, Ko AI, Ndiaye D, Fikrig E, Chuang YM, Bei AK. J Infect Dis. 2024 Oct 30; 2024 Oct 30. PMID: 39475423.
• Noninvasive in vivo photoacoustic detection of malaria with Cytophone in Cameroon.Yadem AC, Armstrong JN, Sarimollaoglu M, Kiki Massa C, Ndifo JM, Menyaev YA, Mbe A, Richards K, Wade M, Zeng Y, Chen R, Zhou Q, Meten E, Ntone R, Tchuedji YLGN, Ullah S, Galanzha EI, Eteki L, Gonsu HK, Biris A, Suen JY, Boum Y 2nd, Zharov VP, Parikh S. Nat Commun. 2024 Oct 25; 2024 Oct 25. PMID: 39455558.
• Persistent and multiclonal malaria parasite dynamics despite extended artemether-lumefantrine treatment in children.Goodwin J, Kajubi R, Wang K, Li F, Wade M, Orukan F, Huang L, Whalen M, Aweeka FT, Mwebaza N, Parikh S. Nat Commun. 2024 May 7; 2024 May 7. PMID: 38714692.
• Two mosquito salivary antigens demonstrate promise as biomarkers of recent exposure to P. falciparum infected mosquito bites.Lapidus S, Goheen MM, Sy M, Deme AB, Ndiaye IM, Diedhiou Y, Mbaye AM, Hagadorn KA, Sene SD, Pouye MN, Thiam LG, Ba A, Guerra N, Mbengue A, Raduwan H, Vigan-Womas I, Parikh S, Ko AI, Ndiaye D, Fikrig E, Chuang YM, Bei AK. medRxiv. 2024 Apr 22; 2024 Apr 22. PMID: 38712295.
• Lessons Learned from the Connecticut Response to COVID-19 in Nursing Homes during the First 2 Years of the Pandemic.Goodwin J, Harizaj A, Armstrong J, Maloney M, Ehrlich H, Leung V, Parikh S. J Am Med Dir Assoc. 2023 Oct; 2023 Aug 14. PMID: 37591486.
• Tracking antimalarial drug resistance using mosquito blood meals: a cross-sectional study.Ehrlich HY, Somé AF, Bazié T, Ebou CN, Dembélé EL, Balma R, Goodwin J, Wade M, Bei AK, Ouédraogo JB, Foy BD, Dabiré RK, Parikh S. Lancet Microbe. 2023 Jun; 2023 Apr 20. PMID: 37086737.
• Moving towards malaria elimination with safer treatment for children with G6PD deficiency.Boum Y, Moukoko CEE, Parikh S. Lancet Infect Dis. 2023 Apr; 2022 Nov 30. PMID: 36462525.
• Repeat Ivermectin Mass Drug Administrations for Malaria Control II: Protocol for a Double-blind, Cluster-Randomized, Placebo-Controlled Trial for the Integrated Control of Malaria.Foy BD, Some A, Magalhaes T, Gray L, Rao S, Sougue E, Jackson CL, Kittelson J, Slater HC, Bousema T, Da O, Coulidiaty AGV, Colt M, Wade M, Richards K, Some AF, Dabire RK, Parikh S. JMIR Res Protoc. 2023 Mar 20; 2023 Mar 20. PMID: 36939832.
• Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda.Kay K, Goodwin J, Ehrlich H, Ou J, Freeman T, Wang K, Li F, Wade M, French J, Huang L, Aweeka F, Mwebaza N, Kajubi R, Riggs M, Ruiz-Garcia A, Parikh S. Clin Pharmacol Ther. 2023 Mar; 2022 Nov 14. PMID: 36260349.
• The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial.Whalen ME, Kajubi R, Goodwin J, Orukan F, Colt M, Huang L, Richards K, Wang K, Li F, Mwebaza N, Aweeka FT, Parikh S. Clin Infect Dis. 2023 Feb 8. PMID: 36130191.
• Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi.Nyangulu W, Mungwira RG, Divala TH, Nampota-Nkomba N, Nyirenda OM, Buchwald AG, Miller J, Earland DE, Adams M, Plowe CV, Taylor TE, Mallewa JE, van Oosterhout JJ, Parikh S, Laurens MB, Laufer MK. Malar J. 2023 Jan 27; 2023 Jan 27. PMID: 36707795.
• Striving towards true equity in global health: A checklist for bilateral research partnerships.Hodson DZ, Etoundi YM, Parikh S, Boum Y 2nd. PLOS Glob Public Health. 2023; 2023 Jan 18. PMID: 36963065.
• Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein.Lapidus S, Liu F, Casanovas-Massana A, Dai Y, Huck JD, Lucas C, Klein J, Filler RB, Strine MS, Sy M, Deme AB, Badiane AS, Dieye B, Ndiaye IM, Diedhiou Y, Mbaye AM, Diagne CT, Vigan-Womas I, Mbengue A, Sadio BD, Diagne MM, Moore AJ, Mangou K, Diallo F, Sene SD, Pouye MN, Faye R, Diouf B, Nery N Jr, Costa F, Reis MG, Muenker MC, Hodson DZ, Mbarga Y, Katz BZ, Andrews JR, Campbell M, Srivathsan A, Kamath K, Baum-Jones E, Faye O, Sall AA, Vélez JCQ, Cappello M, Wilson M, Ben-Mamoun C, Tedder R, McClure M, Cherepanov P, Somé FA, Dabiré RK, Moukoko CEE, Ouédraogo JB, Boum Y 2nd, Shon J, Ndiaye D, Wisnewski A, Parikh S, Iwasaki A, Wilen CB, Ko AI, Ring AM, Bei AK. Sci Rep. 2022 Dec 22; 2022 Dec 22. PMID: 36550362.
• Clinical characteristics of Plasmodium falciparum infection among symptomatic patients presenting to a major urban military hospital in Cameroon.Hodson DZ, Mbarga Etoundi Y, Mbatou Nghokeng N, Mohamadou Poulibe R, Magne Djoko S, Goodwin J, Cheteug Nguesta G, Nganso T, Armstrong JN, Andrews JJ, Zhang E, Wade M, Eboumbou Moukoko CE, Boum Y 2nd, Parikh S. Malar J. 2022 Oct 22; 2022 Oct 22. PMID: 36273147.
• Genetic Variants of Glucose-6-Phosphate Dehydrogenase and Their Associated Enzyme Activity: A Systematic Review and Meta-Analysis.Pfeffer DA, Satyagraha AW, Sadhewa A, Alam MS, Bancone G, Boum Y 2nd, Brito M, Cui L, Deng Z, Domingo GJ, He Y, Khan WA, Kibria MG, Lacerda M, Menard D, Monteiro W, Pal S, Parikh S, Roca-Feltrer A, Roh M, Sirdah MM, Wang D, Huang Q, Howes RE, Price RN, Ley B. Pathogens. 2022 Sep 14; 2022 Sep 14. PMID: 36145477.
• Towards rainbow portable Cytophone with laser diodes for global disease diagnostics.Jawad HJ, Yadem AC, Menyaev YA, Sarimollaoglu M, Armstrong JN, Watanabe F, Biris AS, Stumhofer JS, Nedosekin D, Suen JY, Parikh S, Zharov VP. Sci Rep. 2022 May 23; 2022 May 23. PMID: 35606373.
• Repeatability and reproducibility of a handheld quantitative G6PD diagnostic.Ley B, Winasti Satyagraha A, Kibria MG, Armstrong J, Bancone G, Bei AK, Bizilj G, Brito M, Ding XC, Domingo GJ, von Fricken ME, Gornsawun G, Lam B, Menard D, Monteiro W, Ongarello S, Pal S, Panggalo LV, Parikh S, Pfeffer DA, Price RN, da Silva Orfano A, Wade M, Wojnarski M, Worachet K, Yar A, Alam MS, Howes RE. PLoS Negl Trop Dis. 2022 Feb; 2022 Feb 17. PMID: 35176015.
• Repeat positive SARS-CoV-2 RNA testing in nursing home residents during the initial 9 months of the COVID-19 pandemic: an observational retrospective analysis.Armstrong JN, Campbell L, Rabatsky-Her T, Leung V, Parikh S. Lancet Reg Health Am. 2021 Nov; 2021 Aug 21. PMID: 34458887.
• Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.Jackson CL, Colborn K, Gao D, Rao S, Slater HC, Parikh S, Foy BD, Kittelson J. Clin Trials. 2021 Oct; 2021 Jul 3. PMID: 34218684.
• Four Human Cases of Eastern Equine Encephalitis in Connecticut, USA, during a Larger Regional Outbreak, 2019.Brown SC, Cormier J, Tuan J, Lier AJ, McGuone D, Armstrong PM, Kaddouh F, Parikh S, Landry ML, Gobeske KT. Emerg Infect Dis. 2021 Aug. PMID: 34289334.
• Mapping partner drug resistance to guide antimalarial combination therapy policies in sub-Saharan Africa.Ehrlich HY, Bei AK, Weinberger DM, Warren JL, Parikh S. Proc Natl Acad Sci U S A. 2021 Jul 20. PMID: 34261791.
• Plasmodium infection induces cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein.Lapidus S, Liu F, Casanovas-Massana A, Dai Y, Huck JD, Lucas C, Klein J, Filler RB, Strine MS, Sy M, Deme AB, Badiane AS, Dieye B, Ndiaye IM, Diedhiou Y, Mbaye AM, Diagne CT, Vigan-Womas I, Mbengue A, Sadio BD, Diagne MM, Moore AJ, Mangou K, Diallo F, Sene SD, Pouye MN, Faye R, Diouf B, Nery N Jr, Costa F, Reis M, Muenker MC, Hodson DZ, Mbarga Y, Katz BZ, Andrews JR, Campbell M, Srivathsan A, Kamath K, Baum-Jones E, Faye O, Sall AA, Quintero Vélez JC, Cappello M, Wilson M, Ben-Mamoun C, Somé FA, Dabiré RK, Moukoko CEE, Ouédraogo JB, Boum Y 2nd, Shon J, Ndiaye D, Wisnewski A, Parikh S, Iwasaki A, Wilen CB, Ko AI, Ring AM, Bei AK. medRxiv. 2021 May 12; 2021 May 12. PMID: 34013301.
• SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA.Ehrlich HY, Harizaj A, Campbell L, Colt M, Yuan K, Rabatsky-Ehr T, Weinberger DM, Leung V, Niccolai LM, Parikh S. Emerg Infect Dis. 2021 May. PMID: 33900171.
• Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021.Britton A, Jacobs Slifka KM, Edens C, Nanduri SA, Bart SM, Shang N, Harizaj A, Armstrong J, Xu K, Ehrlich HY, Soda E, Derado G, Verani JR, Schrag SJ, Jernigan JA, Leung VH, Parikh S. MMWR Morb Mortal Wkly Rep. 2021 Mar 19; 2021 Mar 19. PMID: 33735160.
• Bordetella bronchiseptica: a rare cause of meningitis.Radcliffe C, Lier A, Doilicho N, Parikh S, Kaddouh F. BMC Infect Dis. 2020 Dec 3; 2020 Dec 3. PMID: 33272197.
• Point Prevalence Testing of Residents for SARS-CoV-2 in a Subset of Connecticut Nursing Homes.Parikh S, O'Laughlin K, Ehrlich HY, Campbell L, Harizaj A, Durante A, Leung V. JAMA. 2020 Sep 15. PMID: 32790860.
• Molecular surveillance of antimalarial partner drug resistance in sub-Saharan Africa: a spatial-temporal evidence mapping study.Ehrlich HY, Jones J, Parikh S. Lancet Microbe. 2020 Sep; 2020 Sep 7. PMID: 33089222.
• Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.Saito M, Mansoor R, Kennon K, Anvikar AR, Ashley EA, Chandramohan D, Cohee LM, D'Alessandro U, Genton B, Gilder ME, Juma E, Kalilani-Phiri L, Kuepfer I, Laufer MK, Lwin KM, Meshnick SR, Mosha D, Mwapasa V, Mwebaza N, Nambozi M, Ndiaye JA, Nosten F, Nyunt M, Ogutu B, Parikh S, Paw MK, Phyo AP, Pimanpanarak M, Piola P, Rijken MJ, Sriprawat K, Tagbor HK, Tarning J, Tinto H, Valéa I, Valecha N, White NJ, Wiladphaingern J, Stepniewska K, McGready R, Guérin PJ. Lancet Infect Dis. 2020 Aug; 2020 Apr 29. PMID: 32530424.
• Correction: Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.Pfeffer DA, Ley B, Howes RE, Adu P, Alam MS, Bansil P, Boum Y 2nd, Brito M, Charoenkwan P, Clements A, Cui L, Deng Z, Egesie OJ, Espino FE, von Fricken ME, Hamid MMA, He Y, Henriques G, Khan WA, Khim N, Kim S, Lacerda M, Lon C, Mekuria AH, Menard D, Monteiro W, Nosten F, Oo NN, Pal S, Palasuwan D, Parikh S, Pasaribu AP, Poespoprodjo JR, Price DJ, Roca-Feltrer A, Roh ME, Saunders DL, Spring MD, Sutanto I, LeyThriemer K, Weppelmann TA, Seidlein LV, Satyagraha AW, Bancone G, Domingo GJ, Price RN. PLoS Med. 2020 Jul; 2020 Jul 24. PMID: 32706838.
• Investigating selected host and parasite factors potentially impacting upon seasonal malaria chemoprevention in Bama, Burkina Faso.Somé FA, Bazié T, Ehrlich HY, Goodwin J, Lehane A, Neya C, Zachari K, Wade M, Ouattara JM, Foy BD, Dabiré RK, Parikh S, Ouédraogo JB. Malar J. 2020 Jul 6; 2020 Jul 6. PMID: 32631416.
• Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.Saito M, Mansoor R, Kennon K, Anvikar AR, Ashley EA, Chandramohan D, Cohee LM, D'Alessandro U, Genton B, Gilder ME, Juma E, Kalilani-Phiri L, Kuepfer I, Laufer MK, Lwin KM, Meshnick SR, Mosha D, Muehlenbachs A, Mwapasa V, Mwebaza N, Nambozi M, Ndiaye JA, Nosten F, Nyunt M, Ogutu B, Parikh S, Paw MK, Phyo AP, Pimanpanarak M, Piola P, Rijken MJ, Sriprawat K, Tagbor HK, Tarning J, Tinto H, Valéa I, Valecha N, White NJ, Wiladphaingern J, Stepniewska K, McGready R, Guérin PJ. BMC Med. 2020 Jun 2; 2020 Jun 2. PMID: 32482173.
• Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.Pfeffer DA, Ley B, Howes RE, Adu P, Alam MS, Bansil P, Boum Y 2nd, Brito M, Charoenkwan P, Clements A, Cui L, Deng Z, Egesie OJ, Espino FE, von Fricken ME, Hamid MMA, He Y, Henriques G, Khan WA, Khim N, Kim S, Lacerda M, Lon C, Mekuria AH, Menard D, Monteiro W, Nosten F, Oo NN, Pal S, Palasuwan D, Parikh S, Pitaloka Pasaribu A, Poespoprodjo JR, Price DJ, Roca-Feltrer A, Roh ME, Saunders DL, Spring MD, Sutanto I, Thriemer K, Weppelmann TA, von Seidlein L, Satyagraha AW, Bancone G, Domingo GJ, Price RN. PLoS Med. 2020 May; 2020 May 14. PMID: 32407380.
• An Individual Participant Data Population Pharmacokinetic Meta-analysis of Drug-Drug Interactions between Lumefantrine and Commonly Used Antiretroviral Treatment.Francis J, Barnes KI, Workman L, Kredo T, Vestergaard LS, Hoglund RM, Byakika-Kibwika P, Lamorde M, Walimbwa SI, Chijioke-Nwauche I, Sutherland CJ, Merry C, Scarsi KK, Nyagonde N, Lemnge MM, Khoo SH, Bygbjerg IC, Parikh S, Aweeka FT, Tarning J, Denti P. Antimicrob Agents Chemother. 2020 Apr 21; 2020 Apr 21. PMID: 32071050.
• Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.Hughes E, Mwebaza N, Huang L, Kajubi R, Nguyen V, Nyunt MM, Orukan F, Mwima MW, Parikh S, Aweeka F. J Acquir Immune Defic Syndr. 2020 Feb 1. PMID: 31929402.
• Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.Ley B, Winasti Satyagraha A, Rahmat H, von Fricken ME, Douglas NM, Pfeffer DA, Espino F, von Seidlein L, Henriques G, Oo NN, Menard D, Parikh S, Bancone G, Karahalios A, Price RN. PLoS Med. 2019 Dec; 2019 Dec 13. PMID: 31834890.
• Analysis of the RIMDAMAL trial - Authors' reply.Foy BD, Rao S, Parikh S, Slater HC, Dabiré RK. Lancet. 2019 Sep 21. PMID: 31544742.
• Comparison on simultaneous caillary and venous parasite density and genotyping results from children and adults with uncomplicated malaria: a prospective observational study in Uganda.Lehane A, Were M, Wade M, Hamadu M, Cahill M, Kiconco S, Kajubi R, Aweeka F, Mwebaza N, Li F, Parikh S. BMC Infect Dis. 2019 Jun 26; 2019 Jun 26. PMID: 31242863.
• Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial.Foy BD, Alout H, Seaman JA, Rao S, Magalhaes T, Wade M, Parikh S, Soma DD, Sagna AB, Fournet F, Slater HC, Bougma R, Drabo F, Diabaté A, Coulidiaty AGV, Rouamba N, Dabiré RK. Lancet. 2019 Apr 13; 2019 Mar 14. PMID: 30878222.
• Brief Report: Antimalarial Benefit of HIV Antiretroviral Therapy in Areas of Low to Moderate Malaria Transmission Intensity.Greenhalgh S, Hobbs CV, Parikh S. J Acquir Immune Defic Syndr. 2018 Oct 1. PMID: 30212437.
• Strong correlation of lumefantrine concentrations in capillary and venous plasma from malaria patients.Huang L, Mwebaza N, Kajubi R, Marzan F, Forsman C, Parikh S, Aweeka FT. PLoS One. 2018; 2018 Aug 16. PMID: 30114201.
• Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.Kloprogge F, Workman L, Borrmann S, Tékété M, Lefèvre G, Hamed K, Piola P, Ursing J, Kofoed PE, Mårtensson A, Ngasala B, Björkman A, Ashton M, Friberg Hietala S, Aweeka F, Parikh S, Mwai L, Davis TME, Karunajeewa H, Salman S, Checchi F, Fogg C, Newton PN, Mayxay M, Deloron P, Faucher JF, Nosten F, Ashley EA, McGready R, van Vugt M, Proux S, Price RN, Karbwang J, Ezzet F, Bakshi R, Stepniewska K, White NJ, Guerin PJ, Barnes KI, Tarning J. PLoS Med. 2018 Jun; 2018 Jun 12. PMID: 29894518.
• The role of antimalarial quality in the emergence and transmission of resistance.Brock AR, Ross JV, Parikh S, Esterman A. Med Hypotheses. 2018 Feb; 2017 Dec 14. PMID: 29406996.
• Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral Therapy.Hobbs CV, Gabriel EE, Kamthunzi P, Tegha G, Tauzie J, Li Y, Ilmet T, Artimovich E, Neal J, Hall T, Parikh S, Kirmse B, Jean-Philippe P, Chen J, Prescott WR, Palumbo P, Duffy PE, Borkowsky W, For The P S Study Team. Am J Trop Med Hyg. 2018 Jan. PMID: 29165225.
• Evaluation of the Deki Reader™, an automated RDT reader and data management device, in a household survey setting in low malaria endemic southwestern Uganda.Oyet C, Roh ME, Kiwanuka GN, Orikiriza P, Wade M, Parikh S, Mwanga-Amumpaire J, Boum Y 2nd. Malar J. 2017 Nov 7; 2017 Nov 7. PMID: 29115991.
• Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.Huang L, Carey V, Lindsey JC, Marzan F, Gingrich D, Graham B, Barlow-Mosha L, Ssemambo PK, Kamthunzi P, Nachman S, Parikh S, Aweeka FT. PLoS One. 2017; 2017 Oct 24. PMID: 29065172.
• Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum.Brock AR, Ross JV, Greenhalgh S, Durham DP, Galvani A, Parikh S, Esterman A. Infect Dis Model. 2017 May; 2017 Apr 15. PMID: 29928735.
• Buy one, get one free? Benefits of certain antiretrovirals against malaria.Hobbs CV, Parikh S. AIDS. 2017 Feb 20. PMID: 27662555.
• Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.Hoglund RM, Workman L, Edstein MD, Thanh NX, Quang NN, Zongo I, Ouedraogo JB, Borrmann S, Mwai L, Nsanzabana C, Price RN, Dahal P, Sambol NC, Parikh S, Nosten F, Ashley EA, Phyo AP, Lwin KM, McGready R, Day NP, Guerin PJ, White NJ, Barnes KI, Tarning J. PLoS Med. 2017 Jan; 2017 Jan 10. PMID: 28072872.
• Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children.Kajubi R, Huang L, Were M, Kiconco S, Li F, Marzan F, Gingrich D, Nyunt MM, Ssebuliba J, Mwebaza N, Aweeka FT, Parikh S. Open Forum Infect Dis. 2016 Oct; 2016 Dec 15. PMID: 28018925.
• Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060.Hobbs CV, Gabriel EE, Kamthunzi P, Tegha G, Tauzie J, Petzold E, Barlow-Mosha L, Chi BH, Li Y, Ilmet T, Kirmse B, Neal J, Parikh S, Deygoo N, Jean Philippe P, Mofenson L, Prescott W, Chen J, Musoke P, Palumbo P, Duffy PE, Borkowsky W. PLoS One. 2016; 2016 Dec 9. PMID: 27936233.
• Time series analysis of malaria in Afghanistan: using ARIMA models to predict future trends in incidence.Anwar MY, Lewnard JA, Parikh S, Pitzer VE. Malar J. 2016 Nov 22; 2016 Nov 22. PMID: 27876041.
• Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.Roh ME, Oyet C, Orikiriza P, Wade M, Mwanga-Amumpaire J, Boum Y 2nd, Kiwanuka GN, Parikh S. Am J Trop Med Hyg. 2016 Nov 2; 2016 Sep 26. PMID: 27672207.
• Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.Tchaparian E, Sambol NC, Arinaitwe E, McCormack SA, Bigira V, Wanzira H, Muhindo M, Creek DJ, Sukumar N, Blessborn D, Tappero JW, Kakuru A, Bergqvist Y, Aweeka FT, Parikh S. J Infect Dis. 2016 Oct 15; 2016 Jul 28. PMID: 27471317.
• An Evaluation of the National Malaria Surveillance System of Bhutan, 2006-2012 as It Approaches the Goal of Malaria Elimination.West N, Gyeltshen S, Dukpa S, Khoshnood K, Tashi S, Durante A, Parikh S. Front Public Health. 2016; 2016 Aug 19. PMID: 27595095.
• Asymptomatic Plasmodium Infections in Children in Low Malaria Transmission Setting, Southwestern Uganda(1).Roh ME, Oyet C, Orikiriza P, Wade M, Kiwanuka GN, Mwanga-Amumpaire J, Parikh S, Boum Y 2nd. Emerg Infect Dis. 2016 Aug. PMID: 27434741.
• Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.Parikh S, Kajubi R, Huang L, Ssebuliba J, Kiconco S, Gao Q, Li F, Were M, Kakuru A, Achan J, Mwebaza N, Aweeka FT. Clin Infect Dis. 2016 Aug 1; 2016 May 3. PMID: 27143666.
• Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.Sambol NC, Tappero JW, Arinaitwe E, Parikh S. PLoS One. 2016; 2016 May 16. PMID: 27182702.
• Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.Nyunt MM, Nguyen VK, Kajubi R, Huang L, Ssebuliba J, Kiconco S, Mwima MW, Achan J, Aweeka F, Parikh S, Mwebaza N. Antimicrob Agents Chemother. 2015 Dec 14; 2015 Dec 14. PMID: 26666942.
• Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy.Parikh S, Fehintola F, Huang L, Olson A, Adedeji WA, Darin KM, Morse GD, Murphy RL, Taiwo BO, Akinyinka OO, Adewole IF, Aweeka FT, Scarsi KK. Antimicrob Agents Chemother. 2015 Dec; 2015 Sep 21. PMID: 26392500.
• Comparing the impact of artemisinin-based combination therapies on malaria transmission in sub-Saharan Africa.Ndeffo Mbah ML, Parikh S, Galvani AP. Am J Trop Med Hyg. 2015 Mar; 2015 Jan 26. PMID: 25624402.
• The epidemiological impact of HIV antiretroviral therapy on malaria in children.Greenhalgh S, Ndeffo M, Galvani AP, Parikh S. AIDS. 2015 Feb 20. PMID: 25486414.
• Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.Zongo I, Somé FA, Somda SA, Parikh S, Rouamba N, Rosenthal PJ, Tarning J, Lindegardh N, Nosten F, Ouédraogo JB. PLoS One. 2014; 2014 Aug 18. PMID: 25133389.
• Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy.Scarsi KK, Fehintola FA, Ma Q, Aweeka FT, Darin KM, Morse GD, Akinola IT, Adedeji WA, Lindegardh N, Tarning J, Ojengbede O, Adewole IF, Taiwo B, Murphy RL, Akinyinka OO, Parikh S. J Antimicrob Chemother. 2014 May; 2014 Jan 19. PMID: 24446424.
• Malaria diagnostics in clinical trials.Murphy SC, Shott JP, Parikh S, Etter P, Prescott WR, Stewart VA. Am J Trop Med Hyg. 2013 Nov; 2013 Sep 23. PMID: 24062484.
• Biochemical and immunological mechanisms by which sickle cell trait protects against malaria.Gong L, Parikh S, Rosenthal PJ, Greenhouse B. Malar J. 2013 Sep 11; 2013 Sep 11. PMID: 24025776.
• Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.Creek DJ, Bigira V, McCormack S, Arinaitwe E, Wanzira H, Kakuru A, Tappero JW, Sandison TG, Lindegardh N, Nosten F, Aweeka FT, Parikh S. J Infect Dis. 2013 Jun 1; 2013 Feb 27. PMID: 23447696.
• Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers.Huang L, Parikh S, Rosenthal PJ, Lizak P, Marzan F, Dorsey G, Havlir D, Aweeka FT. J Acquir Immune Defic Syndr. 2012 Nov 1. PMID: 22918158.
• In vitro metabolism of piperaquine is primarily mediated by CYP3A4.Lee TM, Huang L, Johnson MK, Lizak P, Kroetz D, Aweeka F, Parikh S. Xenobiotica. 2012 Nov; 2012 Jun 6. PMID: 22671777.
• Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults.Fehintola FA, Scarsi KK, Ma Q, Parikh S, Morse GD, Taiwo B, Akinola IT, Adewole IF, Lindegardh N, Phakderaj A, Ojengbede O, Murphy RL, Akinyinka OO, Aweeka FT. AIDS Res Treat. 2012; 2012 Mar 5. PMID: 22500218.
• Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.Mwesigwa J, Parikh S, McGee B, German P, Drysdale T, Kalyango JN, Clark TD, Dorsey G, Lindegardh N, Annerberg A, Rosenthal PJ, Kamya MR, Aweeka F. Antimicrob Agents Chemother. 2010 Jan; 2009 Oct 19. PMID: 19841149.
• Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility.Johnson MK, Clark TD, Njama-Meya D, Rosenthal PJ, Parikh S. PLoS One. 2009 Sep 30; 2009 Sep 30. PMID: 19789650.
• Plagiarism.Brentlinger PE, Behrens CB, Micek MA, Steketee RW, Andrews KT, Skinner-Adams TS, Gardiner DL, McCarthy JS, Parikh S, ter Kuile F, Ayisi J. Trans R Soc Trop Med Hyg. 2009 Aug. PMID: 19595302.
• Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers.German P, Parikh S, Lawrence J, Dorsey G, Rosenthal PJ, Havlir D, Charlebois E, Hanpithakpong W, Lindegardh N, Aweeka FT. J Acquir Immune Defic Syndr. 2009 Aug 1. PMID: 19506482.
• Experimental malaria infection triggers early expansion of natural killer cells.Kim CC, Parikh S, Sun JC, Myrick A, Lanier LL, Rosenthal PJ, DeRisi JL. Infect Immun. 2008 Dec; 2008 Sep 29. PMID: 18824529.
• Human genetics and malaria: relevance for the design of clinical trials.Parikh S, Rosenthal PJ. J Infect Dis. 2008 Nov 1. PMID: 18752442.
• Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin.Parikh S, Liu J, Sijwali P, Gut J, Goldberg DE, Rosenthal PJ. Antimicrob Agents Chemother. 2006 Jun. PMID: 16723585.
• Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors.Parikh S, Gut J, Istvan E, Goldberg DE, Havlir DV, Rosenthal PJ. Antimicrob Agents Chemother. 2005 Jul. PMID: 15980379.
• Host polymorphisms and the incidence of malaria in Ugandan children.Parikh S, Dorsey G, Rosenthal PJ. Am J Trop Med Hyg. 2004 Dec. PMID: 15642965.
• Molecular evaluation of the natural history of asymptomatic parasitemia in Ugandan children.Nsobya SL, Parikh S, Kironde F, Lubega G, Kamya MR, Rosenthal PJ, Dorsey G. J Infect Dis. 2004 Jun 15; 2004 May 24. PMID: 15181569.
• Intravitreal live Gnathostoma spinigerum.Basak SK, Sinha TK, Bhattacharya D, Hazra TK, Parikh S. Indian J Ophthalmol. 2004 Mar. PMID: 15132381.